Skip to content

Clinical study on the treatment of cervical dizziness by intra-disc injection of methylene blue

Clinical study on the treatment of cervical dizziness by intra-disc injection of methylene blue

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012061
Enrollment
Unknown
Registered
2017-07-20
Start date
2017-07-20
Completion date
Unknown
Last updated
2017-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical dizziness

Interventions

Experimental group:Intra-disc injection of methylene blue into the degenerated cervical discs
Control group:Intra-disc injection of normal saline into the degenerated cervical discs

Sponsors

General Hospital of Armed Police Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Aged =18 years old; 2) With symptoms and signs of cervical spondylotic myelopathy or cervical spondylotic radiculopathy; 3) MRI confirmed cervical disc degeneration; 4) Accompanied by dizziness symptoms, with or without: neck pain, neck stiffness, headache, blurred vision, nausea, tinnitus and less common sense of weakness, anxiety, attention and memory and other psychological symptoms; 5) Plan to receive anterior cervical discectomy and fusion surgery; 6) Agreed to join the study and signed a written informed consent.

Exclusion criteria

Exclusion criteria: 1) Any known causes of dizziness; 2) Had received surgery for cervical spondylosis; 3) Accompanied by other spinal diseases; 4) Can not follow this research for personal reasons.

Design outcomes

Primary

MeasureTime frame
Intensity of dizziness;Frequency of dizziness;

Countries

China

Contacts

Public ContactBaogan Peng

General Hospital of Armed Police Force

pengbaogan76611@163.com+86 13801266500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026